Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Kamradt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Family Practice|December 1, 1991
Relationship of infant mortality to the availability of obstetrical care in IndianaD I Allen, J M Kamradt
Oncology Reports|June 19, 1998
The effect of hydrazine sulfate on prostate cancer growthJ M Kamradt, K J Pienta
Seminars in Oncology|December 22, 1999
Novel molecular targets for prostate cancer therapyJ M Kamradt, K J Pienta
Expert Opinion on Pharmacotherapy|March 16, 2001
Etoposide in prostate cancerJ M Kamradt, K J Pienta
Drugs|March 11, 2000
Oral chemotherapy in the treatment of hormone-refractory prostate cancerK J Pienta, J M Kamradt, D C Smith
Cancer Metastasis Reviews|August 24, 1999
Hormone resistance in prostate cancerM J Pilat, J M Kamradt, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Rational use of chemotherapy. It is not just rat poisonJ M Kamradt, E A Klein, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J Pienta
The Prostate|August 22, 2000
Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental studyJ F Williams, H J Muenchen, J M Kamradt, et al.
Anticancer Research|January 19, 1999
Carboplatin-induced cell death in model prostate cancer systemsC S Yee, J M Kamradt, L C Nielsen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Family Practice|December 1, 1991
Relationship of infant mortality to the availability of obstetrical care in IndianaD I Allen, J M Kamradt
Oncology Reports|June 19, 1998
The effect of hydrazine sulfate on prostate cancer growthJ M Kamradt, K J Pienta
Seminars in Oncology|December 22, 1999
Novel molecular targets for prostate cancer therapyJ M Kamradt, K J Pienta
Expert Opinion on Pharmacotherapy|March 16, 2001
Etoposide in prostate cancerJ M Kamradt, K J Pienta
Drugs|March 11, 2000
Oral chemotherapy in the treatment of hormone-refractory prostate cancerK J Pienta, J M Kamradt, D C Smith
Cancer Metastasis Reviews|August 24, 1999
Hormone resistance in prostate cancerM J Pilat, J M Kamradt, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Rational use of chemotherapy. It is not just rat poisonJ M Kamradt, E A Klein, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J Pienta
The Prostate|August 22, 2000
Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental studyJ F Williams, H J Muenchen, J M Kamradt, et al.
Anticancer Research|January 19, 1999
Carboplatin-induced cell death in model prostate cancer systemsC S Yee, J M Kamradt, L C Nielsen, et al.
Pageof 2